Simplify Propel Opportunities ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
SURI price
Table
| Date | SURI close |
|---|---|
| Oct 16, 2026 | $16.63 |
| Oct 19, 2026 | $16.53 |
| Oct 20, 2026 | $16.87 |
| Oct 21, 2026 | $16.89 |
| Oct 22, 2026 | $16.80 |
| Oct 23, 2026 | $16.63 |
| Oct 26, 2026 | $16.74 |
| Oct 27, 2026 | $16.84 |
| Oct 28, 2026 | $17.00 |
| Oct 29, 2026 | $17.24 |
| Oct 30, 2026 | $16.93 |
| Nov 2, 2026 | $16.58 |
| Nov 3, 2026 | $16.55 |
| Nov 4, 2026 | $16.48 |
| Nov 5, 2026 | $16.20 |
| Nov 6, 2026 | $15.99 |
| Nov 9, 2026 | $16.76 |
| Nov 10, 2026 | $16.14 |
| Nov 11, 2026 | $16.17 |
| Nov 12, 2026 | $16.14 |
| Nov 13, 2026 | $15.97 |
| Nov 16, 2026 | $15.70 |
Daily net flows, 1M
Net outflow over the range: −$1M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct 13 | $0 |
| Oct 14 | $0 |
| Oct 15 | $0 |
| Oct 16 | $0 |
| Oct 19 | $0 |
| Oct 20 | $0 |
| Oct 21 | $0 |
| Oct 22 | $0 |
| Oct 23 | $0 |
| Oct 26 | −$502.3K |
| Oct 27 | $0 |
| Oct 28 | $0 |
| Oct 29 | $0 |
| Oct 30 | $0 |
| Nov 2 | $0 |
| Nov 3 | $0 |
| Nov 4 | $0 |
| Nov 5 | $0 |
| Nov 6 | $0 |
| Nov 9 | $0 |
| Nov 10 | $4.8M |
| Nov 11 | $1.3M |
| Nov 12 | −$6.1M |
| Nov 13 | $0 |
Money is leaving — −$570K in net outflows over the past month, about 0.8% of the fund's asset base, while the price has returned -5.8% so far this year. At 2.84% a year it is not the cheapest way in — IVV has a reported fee of 0.03%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | PAGPPLAINS GP HOLDINGS LP | 31.82% | $26.42 | +0.2% | ||
| 2 | QUITAchieve Life Sciences | 8.40% | $6.06 | -4.1% | ||
| 3 | DCTHDELCATH SYSTEMS | 6.09% | $19.87 | -3.3% | ||
| 4 | COLLCOLLEGIUM PHARMACEUTICAL | 3.38% | $25.43 | +0.4% | ||
| 5 | OBIOORCHESTRA BIOMED HOLDINGS | 2.68% | $7.12 | -1.8% | ||
| 6 | PHATPHATHOM PHARMACEUTICALS | 2.15% | $5.88 | -3.0% | ||
| 7 | CORTCORCEPT THERAPEUTICS | 2.14% | $69.22 | -5.1% | ||
| 8 | MISTMILESTONE PHARMACEUTICALS | 2.48% | $0.36 | -29.8% | ||
| 9 | AQSTAQUESTIVE THERAPEUTICS | 1.55% | $3.76 | -3.8% | ||
| 10 | IVAINVENTIVA SA | 1.65% | $3.32 | -9.8% | ||
| 11 | KYTXKYVERNA THERAPEUTICS INC | 1.31% | $4.76 | -5.7% | ||
| 12 | CMPSCOMPASS PATHWAYS | 1.16% | $8.27 | -8.2% | ||
| 13 | CLDXCELLDEX THERAPEUTICS | 0.89% | $28.59 | -0.8% | ||
| 14 | CABACABALETTA BIO | 1.01% | $1.11 | -13.3% | ||
| 15 | IRDOpus Genetics | 0.71% | $4.04 | +1.5% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 19Sector weights
- Health Technology57.63%
- Energy53.37%
- Healthcare46.63%
- Industrial Services19.99%
- ETF10.71%
- Technology3.88%
- Information Technology3.62%
- Other3.38%
- Corporate2.84%
- Communications2.1%
Show as table
| Item | Value (%) |
|---|---|
| Health Technology | 57.63% |
| Energy | 53.37% |
| Healthcare | 46.63% |
| Industrial Services | 19.99% |
| ETF | 10.71% |
| Technology | 3.88% |
| Information Technology | 3.62% |
| Other | 3.38% |
| Corporate | 2.84% |
| Communications | 2.1% |
Country weights
- United States92.57%
- Other7.63%
- Canada3.49%
- France2.31%
- United Kingdom1.63%
- Germany0.42%
Show as table
| Item | Value (%) |
|---|---|
| United States | 92.57% |
| Other | 7.63% |
| Canada | 3.49% |
| France | 2.31% |
| United Kingdom | 1.63% |
| Germany | 0.42% |
| 1 week | -2.8% |
| 1 month | -5.6% |
| 3 months | -18.0% |
| 6 months | -12.8% |
| YTD | -5.8% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$68K |
| 1 month | −$570K |
| 3 months | +$1M |
| YTD | +$1M |
| 1 year | +$1M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Aug | $403.2K |
| Sep | $737.7K |
| Oct | $342.4K |
| Nov | −$68K |
The top holding is 31.8% of the book; the top ten carry 67%. Spread across 33+ names, it behaves like roughly 5 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Due diligence cuts both ways. These funds sit on the same shelf and beat SURI on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $879.1B | +$10.1B | -281bp on fee · 12599× the assets · +$10.1B in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.7B | +$356M | -282bp on fee · 139× the assets · +$356M in over the month | Head-to-head |
| SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.03% | $14.2B | +$235M | -281bp on fee · 204× the assets · +$235M in over the month | Head-to-head |
| IUSG iShares Core S&P U.S. Growth ETF | 0.04% | $32.3B | +$450M | -280bp on fee · 463× the assets · +$450M in over the month | Head-to-head |
| IUSV iShares Core S&P U.S. Value ETF | 0.04% | $27.3B | +$223M | -280bp on fee · 391× the assets · +$223M in over the month | Head-to-head |